- call +1-201-465-4211
- email sales@mrinsights.biz
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
Scope of the Report:
This report focuses on the Anti-Tumor Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.
The worldwide market for Anti-Tumor Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Roche
Novartis
Celgene
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
There are 15 Chapters to deeply display the global Anti-Tumor Drugs market.
Chapter 1, to describe Anti-Tumor Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Tumor Drugs, with sales, revenue, and price of Anti-Tumor Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Tumor Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Tumor Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Tumor Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Tumor Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Surgical
1.2.2 Chemotherapy
1.2.3 Radiation
1.2.4 Targeted
1.2.5 Immunotherapy
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Anti-Tumor Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Anti-Tumor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Anti-Tumor Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Anti-Tumor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Anti-Tumor Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Anti-Tumor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Tumor Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Tumor Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Tumor Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Tumor Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Tumor Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Tumor Drugs Market Analysis by Regions
4.1 Global Anti-Tumor Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Tumor Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Tumor Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
4.5 South America Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
5 North America Anti-Tumor Drugs by Countries
5.1 North America Anti-Tumor Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Tumor Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Tumor Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
6 Europe Anti-Tumor Drugs by Countries
6.1 Europe Anti-Tumor Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Tumor Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Tumor Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
6.3 UK Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
6.4 France Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Tumor Drugs by Countries
7.1 Asia-Pacific Anti-Tumor Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Tumor Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Tumor Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
7.5 India Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
8 South America Anti-Tumor Drugs by Countries
8.1 South America Anti-Tumor Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Tumor Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Tumor Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Tumor Drugs by Countries
9.1 Middle East and Africa Anti-Tumor Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Tumor Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Tumor Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Tumor Drugs Sales and Growth Rate (2013-2018)
10 Global Anti-Tumor Drugs Market Segment by Type
10.1 Global Anti-Tumor Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Tumor Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Tumor Drugs Revenue and Market Share by Type (2013-2018)
10.2 Surgical Sales Growth and Price
10.2.1 Global Surgical Sales Growth (2013-2018)
10.2.2 Global Surgical Price (2013-2018)
10.3 Chemotherapy Sales Growth and Price
10.3.1 Global Chemotherapy Sales Growth (2013-2018)
10.3.2 Global Chemotherapy Price (2013-2018)
10.4 Radiation Sales Growth and Price
10.4.1 Global Radiation Sales Growth (2013-2018)
10.4.2 Global Radiation Price (2013-2018)
10.5 Targeted Sales Growth and Price
10.5.1 Global Targeted Sales Growth (2013-2018)
10.5.2 Global Targeted Price (2013-2018)
10.6 Immunotherapy Sales Growth and Price
10.6.1 Global Immunotherapy Sales Growth (2013-2018)
10.6.2 Global Immunotherapy Price (2013-2018)
11 Global Anti-Tumor Drugs Market Segment by Application
11.1 Global Anti-Tumor Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-Tumor Drugs Market Forecast (2018-2023)
12.1 Global Anti-Tumor Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Tumor Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Tumor Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Tumor Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Tumor Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Tumor Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Tumor Drugs Market Forecast (2018-2023)
12.3 Anti-Tumor Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Tumor Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Tumor Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Tumor Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Tumor Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Tumor Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Tumor Drugs Picture
Table Product Specifications of Anti-Tumor Drugs
Figure Global Sales Market Share of Anti-Tumor Drugs by Types in 2017
Table An
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
